University of California, Los Angeles: Alcoholism trials
The registry lists 18 Alcoholism studies with University of California, Los Angeles as lead sponsor. 3 are open to participants now and 7 have results posted.
Phase 1 3Phase 2 11Phase 3 1No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Endotoxin Exposure to Examine the Role of Inflammation in Alcohol UseNot yet recruitingNCT07452146Phase 2
- Motivation for IV Alcohol Self-Administration in HumansRecruitingNCT06494891Phase 2
- Emergency Medicine Peer Outreach Worker Engagement for RecoveryRecruitingNCT06320015
- An Inflammatory Challenge Using EndotoxinCompletedNCT04310423Phase 2Results posted
- A Novel Human Lab Model for Screening AUD MedicationsCompletedNCT04249882Phase 2Results posted
- Ibudilast for the Treatment of Alcohol Use DisorderCompletedNCT03594435Phase 2Results posted
- Ibudilast and Withdrawal-Related DysphoriaCompletedNCT03489850Phase 2Results posted
- Combining Varenicline and Naltrexone for Smoking CessationCompletedNCT02698215Phase 2Results posted
- Development of Ivermectin for Alcohol Use DisordersCompletedNCT02046200Phase 1/2Results posted
- Naltrexone for Individuals of East Asian DescentCompletedNCT02026011Phase 2Results posted
- Alcoholic Liver Disease and the Gut MicrobiomeActive, not recruitingNCT05007470Not applicable
- Development of a Selective ALDH2 Inhibitor to Treat AUDWithdrawnNCT04311294Phase 2
- Evaluation of a Home-based Community Health Worker Program in Rural Eastern Cape, South AfricaCompletedNCT03517878
- Treatment for Comorbid Social Anxiety and Alcohol Use Disorders.CompletedNCT03428490Not applicable
- Minocycline for Alcohol Use DisorderWithdrawnNCT03244592Phase 1/2
- Cell Phone Technology Targeting ART and Naltrexone Adherence and Alcohol UseCompletedNCT02603471Not applicable
- HIV & Drug Abuse Prevention for South African MenCompletedNCT02358226Phase 3
- Development of Ibudilast for Alcohol Use DisorderCompletedNCT02025998Phase 1